A Clinical Study of Efinopegdutide (MK-6024) in Healthy Chinese Volunteers (MK-6024-011)
Clinical trial NCT06836037 · COMPLETED
Trial details
- NCT number
- NCT06836037
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-05
- Primary completion
- 2023-02-02
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.